Skip to content

Optical Coherence Tomography in STEMI

Plaque Evaluation by Optical Coherence Tomography and Its Association With Microvascular Obstruction in Reperfused STEMI Patients - The POMS Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02791178
Enrollment
35
Registered
2016-06-06
Start date
2016-02-29
Completion date
2018-01-31
Last updated
2016-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI

Brief summary

The overall objective of this research proposal is to use OCT to investigate those morphological culprit plaque characteristics associated with the risk of developing MVO in reperfused STEMI patients.

Detailed description

The specific research objectives include: 1. To use OCT to determine the type of plaque (plaque rupture, plaque erosion or calcified nodule) most associated with the presence and severity of MVO (as measured by IMR and cardiac MRI). 2. To use OCT to investigate the relationship between the extent of tissue protrusion and the amount of residual stent thrombus with the presence and severity of MVO (as measured by IMR and cardiac MRI).

Interventions

PROCEDUREOptical coherence tomography (OCT)

Special camera to study part of your heart that was affected

PROCEDUREIndex of microcirculatory resistance (IMR)

Special wire to study part of your heart that was affected

OTHERCardiac MRI

Special scanner if the heart to assess the damage of your heart

Sponsors

National Heart Centre Singapore
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

1. Confirmed STEMI as per the in-charge consultant based on presenting history, ECG and angiogram findings. 2. \< 12 hours of onset of chest pain. 3. Ability to provide informed consent

Exclusion criteria

1. Previous myocardial infarction or coronary artery bypass graft surgery 2. Cardiac arrest or cardiogenic shock 3. Inability to advance the OCT catheter or to obtain good image quality 4. Ostial lesions 5. Significant renal impairment 6. Contraindications for cardiac MRI 7. Contraindication for adenosine (for IMR measurement)

Design outcomes

Primary

MeasureTime frame
All cause mortalityTwo years

Countries

Singapore

Contacts

Primary ContactMung Peng
wong.mung.peng@nhcs.com.sg6704
Backup ContactDerek Hausenloy
derek.hausenloy@nhcs.com.sg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026